Debate Over Sinovac Jab For Kids

"); jQuery("#212 h3").html("

Related News Programmes

"); });

2021-11-15 HKT 14:26

Share this story

facebook

  • A government advisory panel will meet on Monday to discuss whether children as young as three years old should be allowed to get a Sinovac jab. Image: Shutterstock

    A government advisory panel will meet on Monday to discuss whether children as young as three years old should be allowed to get a Sinovac jab. Image: Shutterstock

Two medical professionals on Monday offered mixed views on whether children as young as three years old should be allowed to get a Sinovac jab ahead of a government advisory panel meeting to discuss the matter.

Sinovac has requested the administration to allow children aged three or above here to get a jab, which is currently only available for people aged 18 or above.

Respiratory medicine expert Leung Chi-chiu believes it is time to lower the age limit, saying many people have got the vaccine around the world without rare adverse events.

Leung pointed out that the Sinovac jab is being given to children aged three or older on the mainland. "Other countries like Chile and Colombia have also extended the age of application down to either six or three," he added.

He said getting younger children vaccinated will help prevent any future outbreaks of the virus.

But president of the Society of Hospital Pharmacists, William Chui, said more information is needed about the Sinovac jab.

He said that while more than 100 million children have already received the vaccine on the mainland, "the problem is we have to know the distribution of age groups, especially for children [aged between] three to five years old, as they are very vulnerable."

Chui called on the authorities to ask Sinovac for more information, saying it published "limited" data in Lancet in June, with only 56 children aged between three and five and 81 aged between six and 11 being involved.

The pharmacist also said the authorities could consider lowering the age limit for the BioNTech vaccine – available currently to local youngsters aged 12 and above – so parents can have a choice.

RECENT NEWS

SBI Holdings To Acquire Bitbank In US$289M Crypto Expansion

SBI Holdings has agreed to acquire Japanese crypto exchange Bitbank in a deal valued at approximately US$289 million, w... Read more

4 Ways Hong Kong Banks Fight Financial Crime Using AI, According To HKMA

The Hong Kong Monetary Authority (HKMA) wants banks to use AI in financial crime as a way to counter cyberattacks and s... Read more

Ripple Launches RLUSD Stablecoin In Japan Through SBI Group

Ripple has launched its US dollar-denominated stablecoin, Ripple USD, in the Japanese market. The expansion follows reg... Read more

SBI And Startale Launch Trust Bank-Backed Yen Stablecoin JPYSC In Japan

SBI Group has introduced its trust based stablecoin JPYSC in partnership with Singapore-based fintech company Startale ... Read more

Visa Study: Digital Wallets Lead Greater Bay Area Payment Preferences

Visa has released its latest Consumer Payment Attitudes Study, highlighting how payment seamlessness is linked to a shi... Read more

European And South Korean Banks Form Project Pangea For FX Settlement

Chainlink, South Korean infrastructure provider FairSquareLab, the Unified Korea Alliance (UniKA), and European stablec... Read more